INMUNE BIO INC. - COMMON STOCK

5.4900

10-January-25 16:45:00

15 minutes delayed

Stocks

+0.1900

+3.58%

Today's range

5.1500 - 5.6650

ISIN

N/A

Source

NASDAQ

INmune Bio, Inc. Announces Fourth Quarter and Full Year 2020 Results and Provides Business Update

04 Mar 2021 16:15:00 By Nasdaq GlobeNewswire
INmune Bio, Inc. to Report Fourth Quarter and Full Year 2020 Financial Results and Provide a Corporate Update on Thursday, March 4

25 Feb 2021 09:00:00 By Nasdaq GlobeNewswire
INmune Bio, Inc. Announces XPro1595 Found to Decrease Neuroinflammation and Neurodegeneration Biomarkers in Patients with Alzheimer’s Disease in Phase 1b Trial

21 Jan 2021 07:00:00 By Nasdaq GlobeNewswire
INmune Bio, Inc. to Host Key Opinion Leader Webinar on Thursday, January 21 at 8 AM ET

13 Jan 2021 08:00:00 By Nasdaq GlobeNewswire

<<
<
3
4
5
6
7
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.